CardiacSense vs. Coros Wearables: Wearable Health Patent Suit Administratively Closed

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case NameCardiacSense Ltd. v. Coros Wearables, Inc.
Case Number6:24-cv-00280 (W.D. Texas)
CourtU.S. District Court for the Western District of Texas (Waco Division)
DurationMay 22, 2024 – August 19, 2024 89 days
OutcomeDefendant Win – Administratively Closed (No Merits Ruling)
Patents at Issue
Accused ProductsCoros Apex, Apex 2, Apex 2 Pro, Apex Pro, Pace 2, Pace 3, Vertix, Vertix 2 GPS Sports Watches

Case Overview

The Parties

⚖️ Plaintiff

Israeli medical-device company specializing in continuous, non-invasive physiological monitoring technology, particularly cardiac and vital-signs sensing wearables.

🛡️ Defendant

U.S.-based manufacturer of premium GPS sports watches and cycling computers, well-regarded among endurance athletes for products integrating heart-rate monitoring, GPS navigation, and performance analytics.

The Patent at Issue

This case involved U.S. Patent No. 7,980,998 B2, which covers wearable physiological-monitoring technology. At its core, the patent addresses methods and apparatus for continuously measuring vital signs — a technology class directly implicated by smartwatches incorporating optical heart-rate sensors and related biometric capabilities. The specific claims asserted were not disclosed in publicly available docket entries at the time of administrative closure.

🔍

Developing a new wearable product?

Check if your biometric sensing technology might infringe this or related patents before launch.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

The case was administratively closed on August 19, 2024, and subsequently dismissed. No damages were awarded, no injunctive relief was granted, and no merits ruling on infringement or validity was issued. The administrative closure was expressly characterized as functionally equivalent to a stay — the docket remains active and the case could be reopened upon motion by either party or on the court’s own initiative.

Verdict Cause Analysis

The pivotal procedural event was Coros’s Unopposed Motion for Extension of Time to answer or otherwise respond to the complaint (Docket No. 7), filed August 16, 2024. Defense counsel cited the need for sufficient time to prepare a substantive response — a standard, well-recognized basis for extensions in complex patent matters.

Critically, the motion was unopposed, signaling either cooperative early-stage litigation posture, ongoing settlement negotiations, or plaintiff’s strategic decision not to antagonize the court by resisting a reasonable request. The court found “good cause” for the extension under Fed. R. Civ. P. 6(b)(1)(A) and, applying the Mire v. Full Spectrum Lending, Inc. administrative-closure framework, removed the case from its active docket pending Coros’s response.

The administrative closure doctrine in the Fifth Circuit allows district courts to manage dockets efficiently when a case cannot meaningfully proceed — for example, when a defendant’s responsive pleading is outstanding. Importantly, closure does not constitute a dismissal with prejudice and preserves all parties’ rights.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in wearable health tech. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation for wearable devices.

  • View all related patents in this technology space
  • See which companies are most active in biometric sensing patents
  • Understand patent claim scope for physiological monitoring
📊 View Patent Landscape
⚠️
High Risk Area

Continuous physiological monitoring in wearables

📋
1 Patent At Issue

US 7,980,998 B2 & related art

🔍
Proactive FTO Recommended

Before product development or launch

✅ Key Takeaways

For Patent Holders & Litigators

Administrative closure under *Mire* (5th Cir.) is a docket-management tool, not a merits ruling — cases remain viable.

Explore precedents →

Filing against an entire product line (eight SKUs) maximizes damages exposure and licensing leverage, even in early-stage proceedings.

Search competitive portfolios →

Unopposed extension motions at the answer stage frequently signal active settlement discussions.

Monitor litigation trends →
🔒
Unlock Strategic FTO & Product Insights
Get actionable guidance for R&D and product teams on navigating the complex IP landscape of wearable health technology.
FTO Best Practices Biometric Sensor IP Risk IP Due Diligence
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified

References

  1. PACER Docket – 6:24-cv-00280 (W.D. Texas)
  2. USPTO Patent Search – US7980998B2
  3. W.D. Texas Local Patent Rules
  4. Mire v. Full Spectrum Lending, Inc., 389 F.3d 163, 167 (5th Cir. 2014)
  5. PatSnap — IP Intelligence Solutions for Law Firms

This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.